← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2008Last known activity
May 20, 2025
Timeline
1960s
- Jun 1, 1969
Dexa Medica Group— Founded
Drugs by trial phase (32 distinct, 46 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (13 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Breast Neoplasms
- Cerebral Infarction
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Endometriosis
- Gastroesophageal Reflux
- Infarction
- Insulin Resistance
- Ischemia
- Myocardial Infarction
- Non-ST Elevated Myocardial Infarction
- Peptic Ulcer
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Polycystic Ovary Syndrome
- Prediabetic State
- ST Elevation Myocardial Infarction
- Stroke
- Syndrome
- Ulcer
Recent trials (46)
- NCT07089329CollaboratorPhase 3May 20, 2025
- NCT06933862CollaboratorN/AMay 15, 2025
- NCT06510257Lead sponsorPhase 2Oct 31, 2024
- NCT06558071Lead sponsorPhase 3Aug 31, 2024
- NCT06497439Lead sponsorPhase 2Aug 31, 2024
- NCT06558006Lead sponsorPhase 2Jun 19, 2024
- NCT07075289CollaboratorPhase 4Apr 1, 2024
- NCT06525155CollaboratorPhase 3Jan 2, 2024
- NCT06100432CollaboratorPhase 4Nov 11, 2023
- NCT06558032Lead sponsorPhase 1Nov 6, 2023
- NCT06558045Lead sponsorPhase 1Jul 6, 2023
- NCT06558058Lead sponsorPhase 1Jun 8, 2023
- NCT06127225Lead sponsorPhase 2Apr 28, 2023
- NCT06127212Lead sponsorN/AMar 8, 2023
- NCT05248802Lead sponsorPhase 3Dec 31, 2022
Details
- Founded
- Tangerang, ID Jun 1, 1969
- Last known activity
- May 20, 2025